HeartBeam, Inc. (BEAT)

US — Healthcare Sector
Peers: FOXO  EUDA  UTRS  NUTX  HCTI  BFRG  MGRX    LIFW  HLTH 

Automate Your Wheel Strategy on BEAT

With Tiblio's Option Bot, you can configure your own wheel strategy including BEAT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol BEAT
  • Rev/Share 0.0
  • Book/Share 0.2478
  • PB 5.6489
  • Debt/Equity 0.0
  • CurrentRatio 5.455
  • ROIC -3.3812

 

  • MktCap 47333591.0
  • FreeCF/Share -0.5135
  • PFCF -3.0346
  • PE -2.0924
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -3.5833

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 3
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
BEAT
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio.

Read More
image for news HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time
BEAT
Published: May 01, 2025 by: Business Wire
Sentiment: Neutral

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time.

Read More
image for news HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
BEAT
Published: April 29, 2025 by: Business Wire
Sentiment: Neutral

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology.

Read More
image for news HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025
BEAT
Published: March 06, 2025 by: Business Wire
Sentiment: Neutral

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 17-21, 2025.

Read More
image for news HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

About HeartBeam, Inc. (BEAT)

  • IPO Date 2021-11-11
  • Website https://www.heartbeam.com
  • Industry Medical - Healthcare Information Services
  • CEO Robert P. Eno
  • Employees 21
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.